摘要 |
<p>The present invention provides a process for preparing benzyl-2-(4-(4- fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2- ylcarbamate (RLT-8), a process for preparing Raltegravir via RLT-8, a process for preparing methyl 2-(2-(benzyloxycarbonylamino)propan-2-yl)-5 -hydroxy-1-methyl-6- oxo-1,6-dihydropyrimidine-4-carboxylate (RLT-7'), a process for preparing Raltegravir via RLT-7', and a process for preparing crystalline form V of Raltegravir potassium.</p> |
申请人 |
ASSIA CHEMICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;HEDVATI, LILACH;EREZ, ROTEM;COHEN, MEITAL;KANSAL, VINOD, KUMAR;RANJAN, HARISH;DAS, DEBASHISH;JAISWAL, SANJAY;SUBBIREDDY, ELLURU |
发明人 |
HEDVATI, LILACH;EREZ, ROTEM;COHEN, MEITAL;KANSAL, VINOD, KUMAR;RANJAN, HARISH;DAS, DEBASHISH;JAISWAL, SANJAY;SUBBIREDDY, ELLURU |